In the Magill circuit, airflow is
Who is credited with the development of the LMA ProSeal?
Which of the following anesthetic agents will produce decreased EEG activity?
What is the cause of muscle pain in a boy who underwent eye surgery under day care anesthesia with succinylcholine and propofol, and who started walking and developed muscle pain 8 hours after the procedure?
After suxamethonium 50mg, apnea persists for one hour.
What is the primary measurement obtained from pulse oximetry in relation to arterial blood?
Awareness during anaesthesia can be assessed by:
Anaesthesia breathing circuit recommended for spontaneous breathing is what?
Second gas effect is exaggerated by which of the following gases when co-administered with halothane?
In which of the following circuits is sodium lime specifically used to absorb CO2?
Explanation: ***Three times the minute volume (M.V.)*** - In a **Magill circuit (Mapleson A)**, for spontaneous respiration, a fresh gas flow (FGF) of **1-1.5 times the minute volume (M.V.)** is sufficient to prevent rebreathing. - However, to ensure efficient CO2 washout and prevent rebreathing during **controlled ventilation**, the FGF needs to be significantly higher, typically **two to three times the minute volume (M.V.)**, with three times being the safest margin. *Half of the minute volume (M.V.)* - This flow rate would be **insufficient** for preventing rebreathing of carbon dioxide in a Magill circuit, especially during controlled ventilation or even spontaneous breathing. - **Inadequate fresh gas flow** would lead to CO2 accumulation and hypercapnia. *Twice the minute volume (M.V.)* - While **twice the minute volume (M.V.)** can be considered a minimum for spontaneous ventilation, for controlled ventilation or to provide a wider margin of safety, **three times the minute volume (M.V.)** is generally recommended to ensure adequate CO2 elimination and prevent rebreathing. - Below 2-3 times M.V., there's an increased risk of CO2 rebreathing. *equal to the minute volume (M.V.)* - A fresh gas flow **equal to the minute volume (M.V.)** in a Magill circuit would lead to significant **rebreathing of exhaled CO2**, as the dead space is not effectively flushed. - This flow rate is only appropriate for Mapleson D circuits during controlled ventilation, not for the Magill circuit.
Explanation: ***Brain*** - Dr. Archie Brain invented the **Laryngeal Mask Airway (LMA)**, and he subsequently developed the **LMA ProSeal**, an advanced version with a gastric access port. - The LMA ProSeal was designed to provide better sealing pressures and allow for gastric decompression while maintaining airway patency. *Bailey* - Dr. Owen Bailey is known for his contributions to **cardiac surgery**, particularly in the field of mitral valve repair. - His work is focused on surgical techniques rather than airway management devices like the LMA. *Macewan* - Sir William Macewan was a prominent 19th-century surgeon known for his pioneering work in **neuro- and general surgery**, including the first successful removal of a brain tumor. - His contributions are in surgical techniques and not in the development of supraglottic airway devices. *Magill* - Sir Ivan Magill was an Irish anesthetist known for his significant contributions to **anesthesia**, including the development of the Magill forceps and the Magill endotracheal tube. - While he developed crucial airway tools, the LMA ProSeal was not among his inventions.
Explanation: ***N2O*** - **Nitrous oxide (N2O)**, a volatile anesthetic, typically causes an **increase in EEG activity** or amplitude, rather than a decrease, particularly at subanesthetic concentrations, indicating cortical arousal. - It maintains **cerebral metabolic rate of oxygen consumption (CMRO2)** and cerebral blood flow (CBF) and does not typically produce burst suppression. *Propofol* - **Propofol** generally produces a **decrease in EEG activity**, progressing to **burst suppression** and then an isoelectric EEG at higher doses, reflecting its profound cerebral depressant effects. - It significantly **reduces cerebral metabolic rate (CMR)** and **intracranial pressure (ICP)**, making it useful in neurosurgery. *Thiopental* - **Thiopental**, a barbiturate, profoundly **decreases EEG activity**, leading to **burst suppression** and an isoelectric EEG at increasing doses. - It significantly **reduces cerebral metabolic rate of oxygen consumption (CMRO2)**, cerebral blood flow (CBF), and intracranial pressure (ICP), providing **neuroprotection**. *Ketamine* - **Ketamine** is unique in that it causes a dissociation between the limbic system and thalamocortical system, leading to a **dissociative anesthetic state** characterized by **increased EEG activity** and disorganized patterns. - It **increases cerebral metabolic rate (CMR)**, cerebral blood flow (CBF), and intracranial pressure (ICP), which can be a concern in patients with pre-existing neurological conditions.
Explanation: ***Succinylcholine-induced myalgia*** - **Succinylcholine** is a depolarizing neuromuscular blocker that can cause transient muscle fasciculations before paralysis, leading to **postoperative myalgia** due to muscle fiber damage. - The onset of muscle pain typically occurs **6-12 hours post-administration**, aligning with the timeframe described in the question. *Effects of anesthesia on muscle* - While general anesthesia can have various systemic effects, directly causing localized **muscle pain** 8 hours post-op in this manner is not its primary or most common presentation. - The specific agents used, such as succinylcholine, are more directly implicated in this type of delayed muscle pain. *Propofol effects on recovery* - **Propofol** is an intravenous anesthetic that generally provides smooth induction and rapid recovery with minimal residual effects. - It is not known to directly cause **postoperative myalgia** or muscle pain as a common side effect. *Early mobilization after surgery* - While early mobilization is generally encouraged for recovery, significant muscle pain 8 hours after minor eye surgery would not typically be solely attributed to "early mobilization." - The type of muscle pain, especially after the administration of specific drugs, points to a more direct pharmacological cause.
Explanation: ***Probably an atypical cholinesterase is present*** - Prolonged apnea after suxamethonium administration is a classic sign of **pseudocholinesterase deficiency**, potentially due to an atypical variant. - An atypical (or inherited deficient) **pseudocholinesterase** cannot metabolize suxamethonium effectively, leading to prolonged neuromuscular blockade. *treatment with cholinesterase is indicated* - Administering cholinesterase is not a standard treatment; rather, treatment focuses on **supportive care** until the drug is metabolized. - Adding more cholinesterase in the presence of an atypical enzyme would not be effective and might even worsen the situation by altering the enzyme's activity. *Treatment with stored blood is indicated* - **Stored blood** containing normal plasma cholinesterase can be considered in very severe, prolonged cases of pseudocholinesterase deficiency. - However, it is not the primary or immediate treatment and is reserved for extreme situations, not merely for "an hour" of apnea, which still typically resolves with supportive care. *Apnea may be due to low serum potassium concentration* - While **hypokalemia** can exacerbate muscle weakness and potentially prolong neuromuscular blockade, it is not the most likely cause of prolonged apnea specifically following suxamethonium. - Myasthenia gravis or other neuromuscular disorders, rather than isolated hypokalemia, are more commonly associated with prolonged apnea independent of pseudocholinesterase deficiency.
Explanation: ***Oxygen saturation*** - Pulse oximetry's primary function is to non-invasively measure the **percentage of hemoglobin molecules** in arterial blood that are carrying oxygen, expressed as **SpO2**. - This measurement reflects the **oxygenation status** of a patient, which is crucial for assessing respiratory and circulatory function. *Rate of flow* - The rate of blood flow is typically assessed using techniques like **Doppler ultrasound** or other methods involving direct measurement or imaging, not pulse oximetry. - Pulse oximetry primarily measures **oxygen saturation** and pulse rate, not the speed of blood movement. *Blood volume* - Blood volume refers to the total amount of blood in the circulatory system and is measured through methods such as **isotope dilution techniques**, not pulse oximetry. - Pulse oximetry provides no direct information about the **quantity of blood** circulating in the body. *Blood coefficient* - The term "blood coefficient" is not a standard physiological measurement obtained from medical devices like pulse oximeters. - This term does not correspond to any specific, commonly measured parameter of arterial blood.
Explanation: ***
Explanation: ***Mapleson A*** - The **Mapleson A circuit**, also known as the Magill circuit, is highly efficient for **spontaneous ventilation** due to the placement of the fresh gas inlet near the patient and the APL valve at the humidifier end. - This arrangement allows for minimal rebreathing of expired gases during spontaneous breathing when the fresh gas flow is adequate. *Mapleson B* - The **Mapleson B circuit** has both the fresh gas inlet and the APL valve close to the patient, making it less efficient for spontaneous breathing compared to Mapleson A. - It requires higher fresh gas flows to prevent rebreathing. *Mapleson C* - The **Mapleson C circuit**, a short version of Mapleson B, is also characterized by the fresh gas inlet and APL valve being near the patient, making it inefficient for spontaneous ventilation. - It is typically used for resuscitation or transport due to its compact nature. *Mapleson D* - The **Mapleson D circuit**, most commonly seen as a Bain system, has the fresh gas inlet near the patient and the APL valve at the reservoir bag end, making it well-suited for **controlled ventilation**. - While it can be used for spontaneous breathing, it is less efficient than the Mapleson A circuit for this purpose.
Explanation: ***Nitrous oxide*** - **Nitrous oxide** has a high partial pressure and low blood solubility, leading to its rapid uptake into the blood and then into the alveoli. - This rapid absorption concentrates the remaining inspired gases, including halothane, thereby exacerbating the **second gas effect** and leading to a more rapid increase in halothane's partial pressure in the alveoli. *Cyclopropane* - While cyclopropane is an anesthetic gas with quick induction, it is no longer widely used and its physiological interaction with other gases in exaggerating the second gas effect is not as pronounced or clinically relevant as that of nitrous oxide. - It has a low MAC and high potency, but its role in the **second gas effect** is not primarily due to its rapid tissue uptake and concentration of other gases in the same manner as nitrous oxide. *Nitrogen (inert gas)* - Nitrogen is an **inert gas** and does not readily participate in physiological processes or anesthetic effects. - Its presence in the inspired gas mixture does not significantly affect the uptake of other anesthetic gases to exaggerate the **second gas effect**. *Helium (low solubility)* - Helium has very **low blood solubility** but is not an anesthetic gas. - Although its low solubility might suggest rapid movement, it would not concentrate other anesthetic gases or directly contribute to the **second gas effect** in the manner of nitrous oxide, which is itself an anesthetic agent with high partial pressure.
Explanation: ***Closed circuit system*** - In a **closed circuit system**, the exhaled gases containing **CO2** are recirculated to the patient after the CO2 is absorbed. - **Sodium lime** is specifically used in these systems to chemically react with and remove the exhaled CO2, preventing its rebreathing by the patient. *Bain's Circuit system* - This is a type of **Mapleson D system**, which is a **semi-open circuit** designed for minimal rebreathing of CO2 by using high fresh gas flow. - **CO2 absorption** is not typically part of the design or function of a Bain's circuit. *Magill's circuit* - The Magill's circuit is a **Mapleson A system**, which is also a **semi-open circuit** where CO2 elimination primarily relies on the fresh gas flow and patient's breathing pattern. - It does **not incorporate a CO2 absorption** canister or sodium lime. *Jackson rebreathing circuit* - The Jackson rebreathing circuit is a variant of the **Mapleson F (Ayre's T-piece)** system, mainly used for pediatric patients. - It functions as a **semi-open non-rebreathing system** (or minimal rebreathing), where CO2 removal depends on fresh gas flow and does not use CO2 absorbents like soda lime.
Anesthesia Machine Components
Practice Questions
Breathing Systems
Practice Questions
Vaporizers
Practice Questions
Gas Cylinders and Pipeline Supply
Practice Questions
Anesthesia Ventilators
Practice Questions
Standard Monitoring: ECG, BP, Pulse Oximetry
Practice Questions
Capnography
Practice Questions
Neuromuscular Monitoring
Practice Questions
Temperature Monitoring
Practice Questions
Invasive Hemodynamic Monitoring
Practice Questions
Equipment Troubleshooting
Practice Questions
Safety Features in Modern Anesthesia Equipment
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free